ZNF254 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.648250E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.595600E-01
Normal-vs-Stage2
1.319830E-02
Normal-vs-Stage3
1.323800E-02
Normal-vs-Stage4
3.928000E-01
Stage1-vs-Stage2
2.562800E-01
Stage1-vs-Stage3
1.780170E-01
Stage1-vs-Stage4
7.972000E-01
Stage2-vs-Stage3
1.419760E-01
Stage2-vs-Stage4
1.549650E-01
Stage3-vs-Stage4
5.805500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.707740E-02
Normal-vs-AfricanAmerican
1.509820E-01
Normal-vs-Asian
4.705700E-02
Caucasian-vs-AfricanAmerican
7.115600E-01
Caucasian-vs-Asian
4.295400E-01
AfricanAmerican-vs-Asian
5.084600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.787570E-02
Normal-vs-Female
2.057700E-02
Male-vs-Female
8.321400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.655400E-01
Normal-vs-Age(41-60Yrs)
5.184200E-02
Normal-vs-Age(61-80Yrs)
9.742400E-03
Normal-vs-Age(81-100Yrs)
1.416010E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.979600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.742000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.187500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.721800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.770300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.125200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.137750E-02
Normal-vs-Daily Drinker
4.296800E-03
Normal-vs-Weekly Drinker
6.838300E-03
Normal-vs-Occasional Drinker
2.131900E-02
Normal-vs-Social Drinker
5.687800E-02
Non Drinker-vs-Daily Drinker
7.331600E-01
Non Drinker-vs-Weekly Drinker
5.954600E-01
Non Drinker-vs-Occasional Drinker
5.742600E-01
Non Drinker-vs-Social Drinker
2.790400E-01
Daily Drinker-vs-Weekly Drinker
8.016400E-01
Daily Drinker-vs-Occasional Drinker
3.752200E-01
Daily Drinker-vs-Social Drinker
1.646370E-01
Weekly Drinker-vs-Occasional Drinker
3.153800E-01
Weekly Drinker-vs-Social Drinker
1.543010E-01
Occasional Drinker-vs-Social Drinker
5.916800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.942500E-02
Normal-vs-Grade 2
6.679300E-03
Normal-vs-Grade 3
9.576400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.590000E-01
Grade 1-vs-Grade 3
9.110000E-01
Grade 1-vs-Grade 4
2.942500E-02
Grade 2-vs-Grade 3
7.086400E-01
Grade 2-vs-Grade 4
6.679300E-03
Grade 3-vs-Grade 4
9.576400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.437500E-03
Normal-vs-NonDiabetic
8.742600E-03
Diabetic-vs-NonDiabetic
8.854600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.603100E-03
Normal-vs-NoPancreatitis
8.255500E-03
Pancreatitis-vs-NoPancreatitis
2.583400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.748500E-02
Normal-vs-N1
1.394130E-02
N0-vs-N1
6.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.460300E-02
Normal-vs-TP53-NonMutant
9.796300E-02
TP53-Mutant-vs-TP53-NonMutant
1.657420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
